|
시장보고서
상품코드
2054891
생식 유전학 시장 : 기술별Reproductive Genetics Market, By Technology (Preimplantation Genetic Testing (, Carrier Screening, Prenatal Genetic Testing,, By Application, By Product Type, By Sample Type, By End User, By Methodology, By Geography )) |
||||||
생식 유전학 시장은 2026년에 82억 4,000만 달러에 달하고 2033년까지 190억 2,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 12.7%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 82억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 12.70% | 시장 규모 예측(2033년) : | 190억 2,000만 달러 |
세계 생식 유전학 시장은 헬스케어 산업 전반에서 급속히 발전하고 있는 분야로, 생식 건강 상태와 임신 및 출산 결과를 평가하기 위해 고안된 첨단 유전자 검사 및 선별 기술을 포함하고 있습니다.
이 전문 시장은 의료 종사자, 불임 치료 클리닉 및 환자가 생식 계획, 임신 관리, 유전적 위험 평가와 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 지원하는 유전자 분석 서비스 및 제품에 중점을 두고 있습니다. 생식 유전학은 최첨단 분자진단, 유전체 시퀀싱 기술 및 생물정보학 플랫폼을 통합하여, 생식 성공이나 자손의 건강에 영향을 미칠 수 있는 염색체 이상, 유전성 질환 및 유전적 요인을 규명합니다.
이 시장에는 착상 전 유전자 검사(PGT), 비침습적 산전 검사(NIPT), 보인자 선별 검사 및 유전 상담 서비스 등 다양한 검사 방법이 포함됩니다. 전 세계 의료 시스템에서 맞춤형 의료와 예방 의료가 점점 더 중요시되는 가운데, 생식 유전학은 현대의 불임 치료 및 산전 관리 프로토콜에서 필수적인 요소로 부상하고 있습니다.
시장 역학
세계 생식 유전학 시장은 주로 몇 가지 강력한 요인에 의해 주도되고 있으며, 이러한 요인들은 선진국 및 신흥국의 전체 헬스케어 시장에서 시장 확장을 지속적으로 견인하고 있습니다. 유전성 질환 및 염색체 이상 유병률 증가와 더불어 전 세계적으로 고령 출산 추세가 맞물리면서, 종합적인 유전자 선별 검사에 대한 수요가 크게 증가하고 있습니다.
고령 출산, 특히 35세 이후의 임신은 유전적 합병증의 위험이 높아지기 때문에 의료진은 정기적인 유전자 검사 프로토콜을 권장하고 있습니다. 차세대 시퀀싱(NGS), 마이크로어레이 분석 및 인공지능을 활용한 진단 플랫폼의 기술적 발전으로 인해 검사의 정확도는 크게 향상되었으며, 동시에 비용과 결과 도출까지 걸리는 시간은 단축되어 더 폭넓은 환자층이 이러한 서비스를 이용하기 쉬워졌습니다.
조기 유전자 검사의 이점에 대한 의료 종사자와 환자들의 인식이 높아짐에 따라, 불임 치료 클리닉 및 의료 기관에서의 도입률이 증가하고 있습니다. 그러나 시장에는 뚜렷한 성장 억제요인도 존재합니다. 고도의 유전자 검사 절차에 따른 높은 비용은 개발도상국 환자와 종합적인 보험 적용을 받지 못하는 환자에게 이용 장벽이 될 수 있습니다.
각국의 복잡한 규제 및 승인 절차의 차이는 신기술 시장 진입을 저해하고 제품 출시를 지연시킬 수 있습니다. 또한, 유전적 차별이나 유전 정보의 사생활 보호와 관련된 문제 등 유전자 검사와 관련된 윤리적 우려로 인해 특정 환자 집단이 주저할 가능성이 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 생식 유전학 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 생식 유전학 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 생식 유전학 시장 : 기술별(2021-2033년)
제5장 세계의 생식 유전학 시장 : 용도별(2021-2033년)
제6장 세계의 생식 유전학 시장 : 제품 유형별(2021-2033년)
제7장 세계의 생식 유전학 시장 : 샘플 유형별(2021-2033년)
제8장 세계의 생식 유전학 시장 : 최종 사용자별(2021-2033년)
제9장 세계의 생식 유전학 시장 : 방법별(2021-2033년)
제10장 세계의 생식 유전학 시장 : 지역별(2021-2033년)
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
KTH 26.06.19Reproductive Genetics Market is estimated to be valued at USD 8.24 Bn in 2026 and is expected to reach USD 19.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.24 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.70% | 2033 Value Projection: | USD 19.02 Bn |
The global reproductive genetics market represents a rapidly evolving segment within the broader healthcare industry, encompassing advanced genetic testing and screening technologies designed to assess reproductive health and fertility outcomes.
This specialized market focuses on genetic analysis services and products that help healthcare providers, fertility clinics, and patients make informed decisions regarding reproductive planning, pregnancy management, and genetic risk assessment. Reproductive genetics integrates cutting-edge molecular diagnostics, genomic sequencing technologies, and bioinformatics platforms to identify chromosomal abnormalities, genetic disorders, and hereditary conditions that may impact reproductive success or offspring health.
The market encompasses various testing methodologies including preimplantation genetic testing (PGT), non-invasive prenatal testing (NIPT), carrier screening, and genetic counseling services. As healthcare systems worldwide increasingly prioritize personalized medicine and preventive care, reproductive genetics has emerged as a critical component in modern fertility treatments and prenatal care protocols.
Market Dynamics
The global reproductive genetics market is primarily driven by several compelling factors that continue to fuel its expansion across developed and emerging healthcare markets. The increasing prevalence of genetic disorders and chromosomal abnormalities, combined with rising maternal age trends globally, has significantly heightened the demand for comprehensive genetic screening services.
Advanced maternal age, particularly pregnancies after 35 years, carries elevated risks of genetic complications, driving healthcare providers to recommend routine genetic testing protocols. Technological breakthroughs in next-generation sequencing (NGS), microarray analysis, and artificial intelligence-powered diagnostic platforms have substantially improved testing accuracy while reducing costs and turnaround times, making these services more accessible to broader patient populations.
Growing awareness among healthcare professionals and patients regarding the benefits of early genetic detection has fostered increased adoption rates across fertility clinics and healthcare institutions. However, the market faces notable restraints including high costs associated with advanced genetic testing procedures, which may limit accessibility for patients in developing regions or those without comprehensive insurance coverage.
Regulatory complexities and varying approval processes across different countries can impede market entry for new technologies and delay product launches. Additionally, ethical concerns surrounding genetic testing, including issues related to genetic discrimination and privacy of genetic information, may create hesitancy among certain patient demographics.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global reproductive genetics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Agilent Technologies, Revvity (PerkinElmer), Bio-Rad Laboratories, Pacific Biosciences, Oxford Nanopore Technologies, MGI Tech, CooperSurgical, Hamilton Thorne, Vitrolife, Takara Bio, and Promega Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global reproductive genetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reproductive genetics market
Market Segmentation
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Preimplantation Genetic Testing (PGT)
- PGT-A (Aneuploidy)
- PGT-M (Monogenic Disorders)
- PGT-SR (Structural Rearrangements)
- Carrier Screening
- Targeted Mutation Panels
- Expanded Carrier Screening
- Prenatal Genetic Testing
- Non-Invasive Prenatal Testing (NIPT)
- Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
- Newborn Genetic Testing
- Whole Exome Sequencing
- Targeted Gene Panels
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Infertility and IVF Programs
- Genetic Disease Risk Assessment
- Chromosomal Abnormality Detection
- Fetal Health Screening
- Inherited Disorder Diagnosis
- Recurrent Pregnancy Loss Investigation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Instruments and Systems
- Sequencers
- PCR Systems
- Microarray Platforms
- Consumables and Reagents
- DNA Extraction Kits
- Amplification Reagents
- Hybridization Probes
- Software and Services
- Genetic Data Analysis Tools
- Counseling and Interpretation Services
- Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Embryo
- Amniotic Fluid
- Maternal Blood
- Buccal Swab
- Cord Blood
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Fertility Clinics and IVF Centers
- Hospitals and Diagnostic Laboratories
- Research and Academic Institutes
- Genetic Counseling Centers
- Methodology Insights (Revenue, USD Bn, 2021 - 2033)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In Situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Microarray Analysis
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- QIAGEN
- Agilent Technologies
- Revvity (PerkinElmer)
- Bio-Rad Laboratories
- Pacific Biosciences
- Oxford Nanopore Technologies
- MGI Tech
- CooperSurgical
- Hamilton Thorne
- Vitrolife
- Takara Bio
- Promega Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Reproductive Genetics Market, By Technology
- Global Reproductive Genetics Market, By Application
- Global Reproductive Genetics Market, By Product Type
- Global Reproductive Genetics Market, By Sample Type
- Global Reproductive Genetics Market, By End User
- Global Reproductive Genetics Market, By Methodology
- Global Reproductive Genetics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Reproductive Genetics Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Preimplantation Genetic Testing (PGT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- PGT-A (Aneuploidy)
- PGT-M (Monogenic Disorders)
- PGT-SR (Structural Rearrangements)
- Carrier Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Targeted Mutation Panels
- Expanded Carrier Screening
- Prenatal Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-Invasive Prenatal Testing (NIPT)
- Invasive Testing (Amniocentesis, Chorionic Villus Sampling)
- Newborn Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Whole Exome Sequencing
- Targeted Gene Panels
5. Global Reproductive Genetics Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Infertility and IVF Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genetic Disease Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chromosomal Abnormality Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fetal Health Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Inherited Disorder Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Recurrent Pregnancy Loss Investigation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Reproductive Genetics Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Instruments and Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sequencers
- PCR Systems
- Microarray Platforms
- Consumables and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- DNA Extraction Kits
- Amplification Reagents
- Hybridization Probes
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genetic Data Analysis Tools
- Counseling and Interpretation Services
7. Global Reproductive Genetics Market, By Sample Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Embryo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Amniotic Fluid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Maternal Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Buccal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Reproductive Genetics Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Fertility Clinics and IVF Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genetic Counseling Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Reproductive Genetics Market, By Methodology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fluorescence In Situ Hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Comparative Genomic Hybridization (CGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microarray Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Reproductive Genetics Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Methodology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revvity (PerkinElmer)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacific Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MGI Tech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CooperSurgical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hamilton Thorne
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vitrolife
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
